Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/057776external-prioritypatent/WO2010036630A2/fr
Application filed by Boehringer Ingelheim IntfiledCriticalBoehringer Ingelheim Int
Publication of TN2011000143A1publicationCriticalpatent/TN2011000143A1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
L'invention concerne des composés de formule (I), qui se lient au récepteur CB2 dont ils sont des agonistes, des antagonistes ou des agonistes inverses, et sont utiles pour le traitement d'une inflammation. Ceux des composés
TN2011000143A2009-09-222011-03-24Composes modulant selectivement le recepteur cb2
TN2011000143A1
(fr)